{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:58:08Z","timestamp":1792468688538,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["SolvingMEFVariants"],"award-info":[{"award-number":["SolvingMEFVariants"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["779295"],"award-info":[{"award-number":["779295"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Familial Mediterranean Fever (FMF) is the most common monogenic autoinflammatory disorder. FMF is caused by mutations in the\n                    <jats:italic>MEFV<\/jats:italic>\n                    gene, encoding pyrin, an inflammasome sensor. The best characterized pathogenic mutations associated with FMF cluster in exon 10. Yet, mutations have been described along the whole\n                    <jats:italic>MEFV<\/jats:italic>\n                    coding sequence. Exon 10 encodes the B30.2 domain of the pyrin protein, but the function of this human-specific domain remains unclear. Pyrin is an inflammasome sensor detecting RhoA GTPase inhibition following exposure to bacterial toxins such as TcdA. Here, we demonstrate that the B30.2 domain is dispensable for pyrin inflammasome activation in response to this toxin. Deletion of the B30.2 domain mimics the most typical FMF-associated mutation and confers spontaneous inflammasome activation in response to pyrin dephosphorylation. Our results indicate that the B30.2 domain is a negative regulator of the pyrin inflammasome that acts independently from and downstream of pyrin dephosphorylation. In addition, we identify the central helical scaffold (CHS) domain of pyrin, which lies immediately upstream of the B30.2 domain as a second regulatory domain. Mutations affecting the CHS domain mimic pathogenic mutations in the B30.2 domain and render the pyrin inflammasome activation under the sole control of the dephosphorylation. In addition, specific mutations in the CHS domain strongly increase the cell susceptibility to steroid catabolites, recently described to activate pyrin, in both a cell line model and in monocytes from genotype-selected FMF patients. Taken together, our work reveals the existence of two distinct regulatory regions at the C-terminus of the pyrin protein, that act in a distinct manner to regulate positively or negatively inflammasome activation. Furthermore, our results indicate that different mutations in pyrin regulatory domains have different functional impacts on the pyrin inflammasome which could contribute to the diversity of pyrin-associated autoinflammatory diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41419-023-05745-9","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T08:02:27Z","timestamp":1679731347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome activation"],"prefix":"10.1038","volume":"14","author":[{"given":"Daria","family":"Chirita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Bronnec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Magnotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dalmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9305-8989","authenticated-orcid":false,"given":"Michel","family":"Popoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Gerfaud-Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Contis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Duquesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetane","family":"Nocturne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lemelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilaine","family":"Boursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0687-8565","authenticated-orcid":false,"given":"Thomas","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"5745_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417\u201326.","journal-title":"Mol Cell"},{"key":"5745_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1600-065X.2011.01041.x","volume":"243","author":"P Broz","year":"2011","unstructured":"Broz P, Monack DM. Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev. 2011;243:174\u201390.","journal-title":"Immunol Rev"},{"key":"5745_CR3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.3777","volume":"18","author":"K Manthiram","year":"2017","unstructured":"Manthiram K, Zhou Q, Aksentijevich I, Kastner DL. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol. 2017;18:832\u201342.","journal-title":"Nat Immunol"},{"key":"5745_CR4","doi-asserted-by":"publisher","first-page":"e10547","DOI":"10.15252\/emmm.201910547","volume":"11","author":"F Magnotti","year":"2019","unstructured":"Magnotti F, Lefeuvre L, Benezech S, Malsot T, Waeckel L, Martin A, et al. Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients. EMBO Mol Med. 2019;11:e10547.","journal-title":"EMBO Mol Med"},{"key":"5745_CR5","doi-asserted-by":"publisher","first-page":"332ra45","DOI":"10.1126\/scitranslmed.aaf1471","volume":"8","author":"SL Masters","year":"2016","unstructured":"Masters SL, Lagou V, Jeru I, Baker PJ, Van Eyck L, Parry DA, et al. Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Sci Transl Med. 2016;8:332ra45.","journal-title":"Sci Transl Med"},{"key":"5745_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3457","author":"YH Park","year":"2016","unstructured":"Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol. 2016. https:\/\/doi.org\/10.1038\/ni.3457","journal-title":"Nat Immunol"},{"key":"5745_CR7","doi-asserted-by":"publisher","first-page":"E4857","DOI":"10.1073\/pnas.1601700113","volume":"113","author":"W Gao","year":"2016","unstructured":"Gao W, Yang J, Liu W, Wang Y, Shao F. Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation. Proc Natl Acad Sci USA. 2016;113:E4857\u20134866.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5745_CR8","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1002\/art.21050","volume":"52","author":"I Jeru","year":"2005","unstructured":"Jeru I, Papin S, L\u2019hoste S, Duquesnoy P, Cazeneuve C, Camonis J, et al. Interaction of pyrin with 14.3.3 in an isoform-specific and phosphorylation-dependent manner regulates its translocation to the nucleus. Arthritis Rheum. 2005;52:1848\u201357.","journal-title":"Arthritis Rheum"},{"key":"5745_CR9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1613156113","author":"H Van Gorp","year":"2016","unstructured":"Van Gorp H, Saavedra PHV, de Vasconcelos NM, Van Opdenbosch N, Vande Walle L, Matusiak M, et al. Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation. Proc Natl Acad Sci USA. 2016. https:\/\/doi.org\/10.1073\/pnas.1613156113","journal-title":"Proc Natl Acad Sci USA"},{"key":"5745_CR10","doi-asserted-by":"crossref","unstructured":"Malik HS, Loeven NA, Delgado JM, Kettenbach AN, Bliska JB. Phosphoprotein Phosphatase Activity Positively Regulates Oligomeric Pyrin to Trigger Inflammasome Assembly in Response to Bacterial Effectors and Toxins that Inactivate RhoA in Macrophages. bioRxiv. 2022: 2022.03.23.485108.","DOI":"10.1101\/2022.03.23.485108"},{"key":"5745_CR11","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1074\/jbc.RA118.005103","volume":"294","author":"I Alimov","year":"2019","unstructured":"Alimov I, Menon S, Cochran N, Maher R, Wang Q, Alford J, et al. Bile acid analogues are activators of pyrin inflammasome. J Biol Chem. 2019;294:3359\u201366.","journal-title":"J Biol Chem"},{"key":"5745_CR12","doi-asserted-by":"publisher","first-page":"111472","DOI":"10.1016\/j.celrep.2022.111472","volume":"41","author":"F Magnotti","year":"2022","unstructured":"Magnotti F, Chirita D, Dalmon S, Martin A, Bronnec P, Sousa J, et al. Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanism. Cell Rep. 2022;41:111472.","journal-title":"Cell Rep."},{"key":"5745_CR13","doi-asserted-by":"publisher","unstructured":"Jamilloux Y, Magnotti F, Belot A, Henry T. The pyrin inflammasome: from sensing RhoA GTPases-inhibiting toxins to triggering autoinflammatory syndromes. Pathog Dis. 2018; 76. https:\/\/doi.org\/10.1093\/femspd\/fty020","DOI":"10.1093\/femspd\/fty020"},{"key":"5745_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","volume":"90","author":"The International FMF Consortium.","year":"1997","unstructured":"The International FMF Consortium. Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever. Cell. 1997;90:797\u2013807.","journal-title":"Cell"},{"key":"5745_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","volume":"17","author":"A candidate gene for familial Mediterranean fever.","year":"1997","unstructured":"A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat Genet. 1997;17:25\u201331.","journal-title":"Nat Genet"},{"key":"5745_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211473","author":"F Moghaddas","year":"2017","unstructured":"Moghaddas F, Llamas R, De Nardo D, Martinez-Banaclocha H, Martinez-Garcia JJ, Mesa-del-Castillo P, et al. A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever. Ann Rheum Dis. 2017. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211473","journal-title":"Ann Rheum Dis"},{"key":"5745_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/sj.ejhg.5200658","volume":"9","author":"I Touitou","year":"2001","unstructured":"Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet. 2001;9:473\u201383.","journal-title":"Eur J Hum Genet"},{"key":"5745_CR18","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jaci.2019.07.039","volume":"144","author":"T Shiba","year":"2019","unstructured":"Shiba T, Tanaka T, Ida H, Watanabe M, Nakaseko H, Osawa M, et al. Functional evaluation of the pathological significance of MEFV variants using induced pluripotent stem cell-derived macrophages. J Allergy Clin Immunol. 2019;144:1438\u201341.e12.","journal-title":"J Allergy Clin Immunol"},{"key":"5745_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/rheumatology\/kex373","volume":"57","author":"Y Jamilloux","year":"2018","unstructured":"Jamilloux Y, Lefeuvre L, Magnotti F, Martin A, Benezech S, Allatif O, et al. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome. Rheumatol (Oxf). 2018;57:100\u201311.","journal-title":"Rheumatol (Oxf)"},{"key":"5745_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/annrheumdis-2012-202774","volume":"73","author":"A Omenetti","year":"2014","unstructured":"Omenetti A, Carta S, Delfino L, Martini A, Gattorno M, Rubartelli A. Increased NLRP3-dependent interleukin 1beta secretion in patients with familial Mediterranean fever: correlation with MEFV genotype. Ann Rheum Dis. 2014;73:462\u20139.","journal-title":"Ann Rheum Dis"},{"key":"5745_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ajmg.a.20296","volume":"124A","author":"A Aldea","year":"2004","unstructured":"Aldea A, Campistol JM, Arostegui JI, Rius J, Maso M, Vives J, et al. A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder? Am J Med Genet A. 2004;124A:67\u201373.","journal-title":"Am J Med Genet A"},{"key":"5745_CR22","first-page":"554","volume":"59","author":"DM Rowczenio","year":"2020","unstructured":"Rowczenio DM, Youngstein T, Trojer H, Omoyinmi E, Baginska A, Brogan P, et al. British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature. Rheumatol (Oxf). 2020;59:554\u20138.","journal-title":"Rheumatol (Oxf)"},{"key":"5745_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01021-7","author":"Y Honda","year":"2021","unstructured":"Honda Y, Maeda Y, Izawa K, Shiba T, Tanaka T, Nakaseko H, et al. Rapid Flow Cytometry-Based Assay for the Functional Classification of MEFV Variants. J Clin Immunol. 2021. https:\/\/doi.org\/10.1007\/s10875-021-01021-7","journal-title":"J Clin Immunol"},{"key":"5745_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41590-020-0705-6","volume":"21","author":"YH Park","year":"2020","unstructured":"Park YH, Remmers EF, Lee W, Ombrello AK, Chung LK, Shilei Z, et al. Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis. Nat Immunol. 2020;21:857\u201367.","journal-title":"Nat Immunol"},{"key":"5745_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/prot.25494","volume":"86","author":"G Arakelov","year":"2018","unstructured":"Arakelov G, Arakelov V, Nazaryan K. Complex formation dynamics of native and mutated pyrin\u2019s B30.2 domain with caspase-1. Proteins. 2018;86:676\u201383.","journal-title":"Proteins"},{"key":"5745_CR26","doi-asserted-by":"publisher","first-page":"9982","DOI":"10.1073\/pnas.0602081103","volume":"103","author":"JJ Chae","year":"2006","unstructured":"Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1\u03b2 production. Proc Natl Acad Sci USA. 2006;103:9982.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5745_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s43141-022-00300-z","volume":"20","author":"AG Fayez","year":"2022","unstructured":"Fayez AG, Eldeen GN, Zarouk WA, Hamed K, Ramadan A, Foda BM, et al. Dynamic disequilibrium-based pathogenicity model in mutated pyrin\u2019s B30.2 domain-Casp1\/p20 complex. J Genet Eng Biotechnol. 2022;20:31.","journal-title":"J Genet Eng Biotechnol"},{"key":"5745_CR28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/humu.20720","volume":"29","author":"F Milhavet","year":"2008","unstructured":"Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008;29:803\u20138.","journal-title":"Hum Mutat"},{"key":"5745_CR29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/hmg\/7.8.1317","volume":"7","author":"A Bernot","year":"1998","unstructured":"Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, Castet V, et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet. 1998;7:1317\u201325.","journal-title":"Hum Mol Genet"},{"key":"5745_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218366","author":"F Magnotti","year":"2020","unstructured":"Magnotti F, Malsot T, Georgin-Lavialle S, Abbas F, Martin A, Belot A, et al. Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor. Ann Rheum Dis. 2020. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218366","journal-title":"Ann Rheum Dis"},{"key":"5745_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787\u201391.","journal-title":"J Immunol"},{"key":"5745_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","volume":"49","author":"BF Py","year":"2013","unstructured":"Py BF, Kim M-S, Vakifahmetoglu-Norberg H, Yuan J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell. 2013;49:331\u20138.","journal-title":"Mol Cell"},{"key":"5745_CR33","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1084\/jem.20160933","volume":"214","author":"A Stutz","year":"2017","unstructured":"Stutz A, Kolbe C-C, Stahl R, Horvath GL, Franklin BS, van Ray O, et al. NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain. J Exp Med. 2017;214:1725\u201336.","journal-title":"J Exp Med"},{"key":"5745_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1083\/jcb.201503023","volume":"210","author":"T Kimura","year":"2015","unstructured":"Kimura T, Jain A, Choi SW, Mandell MA, Schroder K, Johansen T, et al. TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. J Cell Biol. 2015;210:973\u201389.","journal-title":"J Cell Biol"},{"key":"5745_CR35","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/sj.cdd.4402142","volume":"14","author":"S Papin","year":"2007","unstructured":"Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ. 2007;14:1457\u201366.","journal-title":"Cell Death Differ"},{"key":"5745_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jmb.2009.08.059","volume":"394","author":"C Weinert","year":"2009","unstructured":"Weinert C, Grutter C, Roschitzki-Voser H, Mittl PRE, Grutter MG. The crystal structure of human pyrin b30.2 domain: implications for mutations associated with familial Mediterranean fever. J Mol Biol. 2009;394:226\u201336.","journal-title":"J Mol Biol"},{"key":"5745_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature13449","volume":"513","author":"H Xu","year":"2014","unstructured":"Xu H, Yang J, Gao W, Li L, Li P, Zhang L, et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature. 2014;513:237\u201341.","journal-title":"Nature"},{"key":"5745_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep10819","volume":"5","author":"C Weinert","year":"2015","unstructured":"Weinert C, Morger D, Djekic A, Grutter MG, Mittl PRE. Crystal structure of TRIM20 C-terminal coiled-coil\/B30.2 fragment: implications for the recognition of higher order oligomers. Sci Rep. 2015;5:10819.","journal-title":"Sci Rep."},{"key":"5745_CR39","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1136\/annrheumdis-2011-200977","volume":"71","author":"S Federici","year":"2012","unstructured":"Federici S, Calcagno G, Finetti M, Gallizzi R, Meini A, Vitale A, et al. Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. Ann Rheum Dis. 2012;71:1961\u20135.","journal-title":"Ann Rheum Dis"},{"key":"5745_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jpeds.2019.02.039","volume":"209","author":"G Boursier","year":"2019","unstructured":"Boursier G, Hentgen V, Sarrabay G, Kone-Paut I, Touitou I. The Changing Concepts Regarding the Mediterranean Fever Gene: Toward a Spectrum of Pyrin-Associated Autoinflammatory Diseases with Variable Heredity. J Pediatr. 2019;209:12\u201316.e1.","journal-title":"J Pediatr"},{"key":"5745_CR41","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1073\/pnas.1019736108","volume":"108","author":"KL Meerbrey","year":"2011","unstructured":"Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA. 2011;108:3665\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5745_CR42","doi-asserted-by":"publisher","unstructured":"B L, S B, P W, F M, A P, F M et al. Human caspase-4 detects tetra-acylated LPS and cytosolic Francisella and functions differently from murine caspase-11. Nat Commun. 2018; 9. https:\/\/doi.org\/10.1038\/s41467-017-02682-y","DOI":"10.1038\/s41467-017-02682-y"},{"key":"5745_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1128\/iai.55.1.35-43.1987","volume":"55","author":"MR Popoff","year":"1987","unstructured":"Popoff MR. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect Immun. 1987;55:35\u201343.","journal-title":"Infect Immun"},{"key":"5745_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0882-4010(87)90073-8","volume":"2","author":"C von Eichel-Streiber","year":"1987","unstructured":"von Eichel-Streiber C, Harperath U, Bosse D, Hadding U. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related. Micro Pathog. 1987;2:307\u201318.","journal-title":"Micro Pathog"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05745-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05745-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05745-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T08:02:40Z","timestamp":1679731360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05745-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["5745"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-05745-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2214035\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]},"assertion":[{"value":"8 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the French Comit\u00e9 de Protection des Personnes SUD-EST IV (CPP,#L16\u2013189), Ile de France IV (CPP, #2018\/95) and by the French Comit\u00e9 Consultatif sur le Traitement de l\u2019Information en mati\u00e8re de Recherche dans le domaine de la Sant\u00e9 (CCTIRS, #16.864). The authors observed a strict accordance to the Helsinki Declaration guidelines. HD blood was provided by the Etablissement Fran\u00e7ais du Sang in the framework of the convention #14\u20131820. Informed consent was obtained from all healthy donors and patients. All FMF patients fulfilled the Tel Hashomer criteria for FMF. The potential carriage of <i>MEFV<\/i> mutations in HD was not assessed. Blood samples from HD were drawn on the same day as patients. The number of patients in each experiment is reported in the corresponding figure panels.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"213"}}